Stockscreener 앱 받기
6.75
4.12%
-0.29
전일 마감가:
$7.04
열려 있는:
$7.06
하루 거래량:
4.27M
Relative Volume:
1.06
시가총액:
$1.64B
수익:
$386.15M
순이익/손실:
$-56.39M
주가수익비율:
-29.35
EPS:
-0.23
순현금흐름:
$-55.19M
1주 성능:
-12.79%
1개월 성능:
+12.50%
6개월 성능:
+46.74%
1년 성능:
+30.81%
1일 변동 폭
$6.73
$7.15
1주일 범위
$6.73
$7.7399
52주 변동 폭
$3.21
$8.05
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
ARDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
6.75 | 1.71B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | 재개 | Raymond James | Strong Buy |
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-05-02 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | 재개 | Ladenburg Thalmann | Buy |
| 2025-03-04 | 개시 | BTIG Research | Buy |
| 2024-11-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-18 | 개시 | Raymond James | Strong Buy |
| 2023-09-07 | 개시 | H.C. Wainwright | Buy |
| 2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-03-23 | 개시 | Wedbush | Outperform |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 재개 | Citigroup | Buy |
| 2020-02-18 | 재개 | Jefferies | Buy |
| 2020-02-12 | 개시 | Citigroup | Buy |
| 2020-02-10 | 개시 | Cowen | Outperform |
| 2019-04-08 | 개시 | Piper Jaffray | Overweight |
| 2018-08-24 | 개시 | Jefferies | Buy |
| 2018-03-19 | 재개 | Leerink Partners | Outperform |
| 2017-11-29 | 재확인 | Citigroup | Buy |
| 2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
| 2017-10-17 | 재개 | Leerink Partners | Outperform |
| 2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
| 2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
| 2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
Ardelyx says 2025 total product revenue was about $378M - MSN
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Exit Recap: Can Ardelyx Inc continue delivering strong returns2025 Market Sentiment & Real-Time Volume Surge Alerts - baoquankhu1.vn
Insider Buy: Can Ardelyx Inc stock outperform in 2025 bull market2025 Biggest Moves & Consistent Income Trade Ideas - Bộ Nội Vụ
Ardelyx (ARDX) Price Target Increased by 12.82% to 13.46 - Nasdaq
Ardelyx Stock Is Rallying – What Is Making Retail So Bullish? - Asianet Newsable
Lobbying Update: $30,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
Ardelyx (NASDAQ:ARDX) Stock Price Down 6.8% on Insider Selling - MarketBeat
Are Medical Stocks Lagging Ardelyx (ARDX) This Year? - Yahoo Finance
Ardelyx Inc: Citigroup raises target price to $14 from $11 - marketscreener.com
Top Ardelyx Executive Executes Significant Stock Sale That Investors Can’t Ignore - TipRanks
Ardelyx chief patient officer Williams sells $348,900 in stock By Investing.com - Investing.com Canada
Ardelyx chief patient officer Williams sells $348,900 in stock - Investing.com India
Insider Selling: Ardelyx (NASDAQ:ARDX) Insider Sells 50,000 Shares of Stock - MarketBeat
Ardelyx’s Stock Ascends Following Strategic Upgrades and Promising Revenue Projections - StocksToTrade
Why Ardelyx (ARDX) Is Up 20.1% After Lawsuit Dismissal And Patent Extension For Tenapanor - simplywall.st
Ardelyx upgraded at Piper Sandler on Ibsrela (ARDX:NASDAQ) - Seeking Alpha
Assessing Ardelyx (ARDX) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
ARDX Analyst Upgrade: Citigroup Raises Price Target to $14.00 | - GuruFocus
Ardelyx Surges Following Analysts’ Bold Price Target Upgrades - timothysykes.com
Stock Traders Buy High Volume of Ardelyx Call Options (NASDAQ:ARDX) - MarketBeat
American Airlines To Rally More Than 27%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Ardelyx Stock Rises Premarket As Piper Sees Over 100% Upside — Says Constipation Drug ‘Stole The Show’ With 2026 Guidance - Asianet Newsable
Why The Ardelyx ARDX Story Is Shifting On New Ibsrela Targets And Valuation Assumptions - Yahoo Finance
Ardelyx stock rises premarket as Piper sees over 100% upside — says constipation drug 'stole the show' with 2026 guidance - MSN
BTIG Raises Ardelyx (ARDX) Price Target to $17 and Maintains Buy Rating | ARDX Stock News - GuruFocus
Published on: 2026-01-09 13:33:32 - ulpravda.ru
Ardelyx stock price target raised to $17 from $14 at BTIG on strong Ibsrela sales - Investing.com Australia
Ardelyx Inc: Piper Sandler raises to overweight from neutral; raises target price to $16 from $10 - marketscreener.com
What hedge fund moves indicate for Ardelyx Inc. (41X) stock2025 Sector Review & Weekly High Return Opportunities - Улправда
Ardelyx stock price target raised to $19 from $16 at Raymond James By Investing.com - Investing.com South Africa
Ardelyx stock price target raised to $19 from $16 at Raymond James - Investing.com Nigeria
How Ardelyx Inc. (41X) stock reacts to fiscal policies2025 Key Lessons & Weekly Momentum Picks - ulpravda.ru
Wall Street analysts see a 92.12% upside in Ardelyx (ARDX): Can the stock really move this high? - MSN
Why hedge funds are buying Ardelyx Inc. stockLayoff News & Daily Oversold Stock Bounce Ideas - ulpravda.ru
Ardelyx (NASDAQ:ARDX) Shares Gap UpStill a Buy? - MarketBeat
Ardelyx Stock Climbs Amid Revised Financial Outlook and Strategic Expansion - timothysykes.com
Ardelyx stock hits 52-week high at 6.79 USD By Investing.com - Investing.com India
Why Ardelyx Inc. stock remains a top recommendation2025 EndofYear Setup & Risk Managed Investment Entry Signals - ulpravda.ru
Ardelyx (ARDX) Projects Significant Revenue Growth for IBSRELA i - GuruFocus
Ardelyx stock hits 52-week high at 6.79 USD - Investing.com
Can Ardelyx Inc. (41X) stock sustain institutional flowsJobs Report & Technical Analysis for Trade Confirmation - ulpravda.ru
Is Ardelyx Inc. stock vulnerable to regulatory risksJuly 2025 Market Mood & Daily Growth Stock Tips - ulpravda.ru
Ardelyx stock rises after reporting strong 2025 revenue, upbeat 2026 outlook By Investing.com - Investing.com South Africa
Assessing Ardelyx (ARDX) Valuation After Mixed Long Term Shareholder Returns - simplywall.st
Ardelyx stock rises after reporting strong 2025 revenue, upbeat 2026 outlook - Investing.com Canada
Ardelyx reports preliminary 2025 revenue and provides 2026 strategic outlook - MarketScreener
ARDX Sees Significant Revenue Growth in 2025 - GuruFocus
Ardelyx files procedural regulatory disclosure update notice - TipRanks
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ardelyx Inc 주식 (ARDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Williams Laura A | Chief Patient Officer |
Jan 08 '26 |
Sale |
6.98 |
50,000 |
348,900 |
361,563 |
4.73%
0.92%
자본화:
|
볼륨(24시간):